Changes of the cardiac architectures and functions for chronic hemodialysis patients with dry weight determined by echocardiography

Blood Purification

Volumn 22, Issue 4, 2004, Pages 351-359

  Chang, Shih Tai ^a   Chen, Chien Chung ^b   Chen, Chan Long ^b   Cheng, Hui Wen ^a   Chung, Chang Min ^a   Yang, Teng Yao ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b LI SHIN HOSPITAL   (Taiwan)

Author keywords

Echocardiography; End stage renal disease; Hemodialysis; Inferior vena cava diameter; Left ventricular hypertrophy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRY WEIGHT; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEART VENTRICLE WALL; HEART WEIGHT; HEMODIALYSIS; HUMAN; INFERIOR CAVA VEIN; KIDNEY FAILURE; MALE; MEASUREMENT; MORPHOLOGY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FUNCTION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SYSTOLE; VENA CAVA, INFERIOR; VENTRICULAR FUNCTION, LEFT;

EID: 4444259127     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080031     Document Type: Article

References (26)

1. Silberberg JS, Barre PE, Prichard SS, Sniderman AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989;36:286-290.
2. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, Metivier F: Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996;50:600-608.
3. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995;5:2024-2031.
4. Harnett JD, Kent GM, Barre PE, Taylor R, Parfrey PS: Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 1994;4:1486-1490.
5. Harnett JD, Parfrey PS, Griffiths SM, Gault MH, Barre P, Guttmann RD: Left ventricular hypertrophy in end-stage renal disease. Nephron 1998;48:107-115.
6. Raine AEG: The susceptible patient. Nephrol Dial Transplant 1996;11(suppl 2):6-10.
7. Kinet JP, Soyeur D, Balland N, Saint-Remy M, Collignon P, Godon JP: Hemodynamic study of hypotension during hemodialysis. Kidney Int 1982;21:868-876.
8. Charra B, Laurent G, Chazot C, Calemard E, Terrat JC, Vanel T, Jean G, Ruffet M: Clinical assessment of dry weight. Nephrol Dial Transplant 1996;11(suppl 2):16-19.
9. Don C, Burns KD, Levine DZ: Body fluid volume status in hemodialysis patients: The value of the chest radiograph. Can Assoc Radiol J 1990;41:123-126.
10. Cheriex EC, Leunissen KM, Janssen JH, Mooy JM, van Hooff JP: Echography of the inferior vena cava is a simple and reliable tool for estimation of 'dry weight' in haemodialysis patients. Nephrol Dial Transplant 1989;4:563-568.
11. Tetsuka T, Ando Y, Ono S, Asano Y: Change in inferior vena caval diameter detected by ultrasonography during and after hemodialysis. ASAIO J 1995;41:105-110.
12. Katzarski K, Charra B, Laurent G, Lopot F, Divino-Filho JC, Nisell J, Bergstrom J: Multifrequency bioimpedance in assessment of dry weight in haemodialysis. Nephrol Dial Transplant 1996;11(suppl 2):20-23.
13. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613-618.
14. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP: Echocardiographic criteria for left ventricular hypertrophy: The Framingham Heart Study. Am J Cardiol 1987;59:956-960.
15. Levin A, Singer J, Thompson CR, Ross H, Lewis M: Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 1996;27:347-354.
16. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O: Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis 1999;34:125-134.
17. London GM, Marchais SJ, Safar ME, Genest AF, Guerin AP, Metivier F, Chedid K, London AM: Aortic and large artery compliance in endstage renal failure. Kidney Int 1990;37:137-142.
18. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME Cuche JL: Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994;90:2786-2796.
19. Schiffrin EL, Deng LY, Larochelle P: Effects of a β-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994;23:83-91.
20. Albaladejo P, Bouaziz H, Duriez M, Gohlke P, Levy BI, Safar ME, Benetos A: Angiotensinconverting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension 1994;23:74-82.
21. Devereux RB, de Simone G, Ganau A, Koren MJ, Mensah GA, Roman MJ: Left ventricular hypertrophy and hypertension. Clin Exp Hypertens 1993;15:1025-1032.
22. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH: Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992;19:1550-1558.
23. Mandelbaum A, Ritz E: Vena cava diameter measurement for estimation of dry weight in haemodialysis patients. Nephrol Dial Transplant 1996;11(suppl 2):24-27.
24. Tetsuka T, Ando Y, Ono S, Asano Y: Change in inferior vena caval diameter detected by ultrasonography during and after hemodialysis. ASAIO J 1995;41:105-110.
25. Hirayama S, Ando Y, Sudo Y, Asano Y: Improvement of cardiac function by dry weight optimization based on interdialysis inferior vena caval diameter. ASAIO J 2002;48:320-325.
26. Chazot C, Charra B, Laurent G, Didier C, Vo Van C, Terrat JC, Calemard E, Vanel T, Ruffet M: Interdialysis blood pressure control by long haemodialysis sessions. Nephrol Dial Transplant 1995;10:831-837.